Keywords
Infant, Newborn
Infant, Newborn, Diseases
How to Cite
Abstract
Background: Neonatal respiratory distress syndrome (NRDS) is a severe clinical condition affecting preterm infants and sometimes those born at term. It is characterised by a decrease in pulmonary surfactant production or function.
Objective: To characterise neonatal respiratory distress syndrome in a tertiary hospital in Paraguay through a retrospective study of the years 2021 and 2022.
Materials and Methods: The study was observational and descriptive, with a retrospective approach. We reviewed records of neonatal patients admitted to the Hospital de Clínicas del Paraguay. Non-probabilistic sampling of consecutive cases, including all medical records of neonates diagnosed with RDS.
Results: During the study period in 2021, 35 were diagnosed with Neonatal Respiratory Distress Syndrome (NRDS) and in 2022, 33 cases of NRDS were registered. The mean birth weight of these neonates was 2374.71 kilograms and the mean gestational age was 34.3 weeks. The reason for discharge was mainly due to improvement in 53 cases, while 15 cases were discharged due to death.
Conclusion: The incidence of cases was 7%; the most frequent comorbidities were metabolic and neurological; surfactant was the treatment of choice and the type of neonatal respiratory distress syndrome (NRDS) in a specific population of neonates was Hyaline Membrane Disease.
References
Khemani RG, Smith L, Lopez-Fernandez YM, Kwok J, Morzov R, Klein MJ, et al. Paediatric acute respiratory distress syndrome incidence and epidemiology (PARDIE): an international, observational study. The Lancet Respiratory Medicine. 1 de febrero de 2019;7(2):115-28.
Reynolds P, Bustani P, Darby C, Alvarez JRF, Fox G, Jones S, et al. Less-Invasive Surfactant Administration for Neonatal Respiratory Distress Syndrome: A Consensus Guideline. NEO. 2021;118(5):586-92.
Genes L, Lacarrubba J, Caballero C, Fonseca R, Mir R, Céspedes E, et al. Morbi-mortalidad en Recién Nacidos de muy Bajo Peso al Nacer. Unidad de Neonatología. Centro Materno Infantil. Hospital de Clínicas. Pediatría (Asunción). abril de 2010;37(1):9-22.
Sotomayor V, Ramirez L, Lacarruba J, Mir R, Jimenez HJ, Campuzano A, et al. Estudio comparativo de morbimortalidad del prematuro tardío y el recién nacido de termino. Hospital de Clínicas. Asunción, Paraguay. Pediatría (Asunción). agosto de 2017;44(2):104-10.
Baseer KAA, Mohamed M, Abd-Elmawgood EA. Risk Factors of Respiratory Diseases Among Neonates in Neonatal Intensive Care Unit of Qena University Hospital, Egypt. Ann Glob Health. 86(1):22.
Chang JW. Risk factor analysis for the development and progression of retinopathy of prematurity. PLOS ONE. 18 de julio de 2019;14(7):e0219934.
Dyer J. Neonatal Respiratory Distress Syndrome: Tackling A Worldwide Problem. P T. enero de 2019;44(1):12-4.
Popescu CR, Cavanagh MMM, Tembo B, Chiume M, Lufesi N, Goldfarb DM, et al. Neonatal sepsis in low-income countries: epidemiology, diagnosis and prevention. Expert Review of Anti-infective Therapy. 3 de mayo de 2020;18(5):443-52.
Rahtu M, Frerichs I, Waldmann AD, Strodthoff C, Becher T, Bayford R, et al. Early Recognition of Pneumothorax in Neonatal Respiratory Distress Syndrome with Electrical Impedance Tomography. Am J Respir Crit Care Med. 15 de octubre de 2019;200(8):1060-1.
Fernández Colomer B, Sánchez-Luna M, de Alba Romero C, Alarcón A, Baña Souto A, Camba Longueira F, et al. Neonatal Infection Due to SARS-CoV-2: An Epidemiological Study in Spain. Frontiers in Pediatrics [Internet]. 2020 [citado 18 de abril de 2023];8. Disponible en: https://www.frontiersin.org/articles/10.3389/fped.2020.580584
Zambrano JES, Caicedo AP. EVOLUCIÓN DEL SÍNDROME DE DISTRÉS RESPIRATORIO AGUDO EN LOS NEONATOS DEL ÁREA DE CUIDADOS INTENSIVOS DEL HOSPITAL “DELFINA TORRES DE CONCHA”: Evolution of Acute Respiratory Distress Syndrome in neonates in the intensive care area of the «Delfina Torres de Concha» hospital. Más Vita. 2021;3(3):8-21.
Bardales Romero DO. Factores de riesgo asociados a síndrome de distrés respiratorio en neonatos hospitalizados en la unidad de cuidados intermedios Hospital de Ventanilla 2022. Risk factors associated with respiratory distress syndrome in neonates hospitalized in the intermediate care unit Hospital de Ventanilla 2022 [Internet]. 18 de diciembre de 2022 [citado 18 de abril de 2023]; Disponible en: https://repositorio.uwiener.edu.pe/handle/20.500.13053/8192
Hessami K, Homayoon N, Hashemi A, Vafaei H, Kasraeian M, Asadi N. COVID-19 and maternal, fetal and neonatal mortality: a systematic review. The Journal of Maternal-Fetal & Neonatal Medicine. 3 de agosto de 2022;35(15):2936-41.
Li S, Zhao D, Cui J, Wang L, Ma X, Li Y. Prevalence, potential risk factors and mortality rates of acute respiratory distress syndrome in Chinese patients with sepsis. J Int Med Res. 1 de febrero de 2020;48(2):0300060519895659.
Ali EAH, Alanazi MIH, Alanazi IAR, Alanazi BAM, Alanazi KA. Prevalence and Outcome of Management of Respiratory Distress Syndrome: A Systematic Review. Arch Pharm Pract. 2023;14(1):23-8.
McNicholas BA, Madotto F, Pham T, Rezoagli E, Masterson CH, Horie S, et al. Demographics, management and outcome of females and males with acute respiratory distress syndrome in the LUNG SAFE prospective cohort study. European Respiratory Journal [Internet]. 1 de octubre de 2019 [citado 18 de abril de 2023];54(4). Disponible en: https://erj.ersjournals.com/content/54/4/1900609
Blauvelt CA, Chiu C, Donovan AL, Prahl M, Shimotake TK, George RB, et al. Acute Respiratory Distress Syndrome in a Preterm Pregnant Patient With Coronavirus Disease 2019 (COVID-19). Obstetrics & Gynecology. julio de 2020;136(1):46.
Donda K, Vijayakanthi N, Dapaah-Siakwan F, Bhatt P, Rastogi D, Rastogi S. Trends in epidemiology and outcomes of respiratory distress syndrome in the United States. Pediatric Pulmonology. 2019;54(4):405-14.
Alfarwati TW, Alamri AA, Alshahrani MA, Al-Wassia H. Incidence, Risk factors and Outcome of Respiratory Distress Syndrome in Term Infants at Academic Centre, Jeddah, Saudi Arabia. Med Arch. junio de 2019;73(3):183-6.
Antoun L, Taweel NE, Ahmed I, Patni S, Honest H. Maternal COVID-19 infection, clinical characteristics, pregnancy, and neonatal outcome: A prospective cohort study. European Journal of Obstetrics & Gynecology and Reproductive Biology. 1 de septiembre de 2020;252:559-62.
Kim F, Polin RA, Hooven TA. Neonatal sepsis. BMJ. 1 de octubre de 2020;371:m3672.
De Bisschop B, Derriks F, Cools F. Early Predictors for INtubation-SURfactant-Extubation Failure in Preterm Infants with Neonatal Respiratory Distress Syndrome: A Systematic Review. NEO. 2020;117(1):33-45.
Ramanathan R, Biniwale M, Sekar K, Hanna N, Golombek S, Bhatia J, et al. Synthetic Surfactant CHF5633 Compared with Poractant Alfa in the Treatment of Neonatal Respiratory Distress Syndrome: A Multicenter, Double-Blind, Randomized, Controlled Clinical Trial. The Journal of Pediatrics. 1 de octubre de 2020;225:90-96.e1.
Banerjee S, Fernandez R, Fox GF, Goss KCW, Mactier H, Reynolds P, et al. Surfactant replacement therapy for respiratory distress syndrome in preterm infants: United Kingdom national consensus. Pediatr Res. julio de 2019;86(1):12-4.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2023 Shirley Rocío Oviedo Ramírez, Deisy Beatriz Colmán Gómez, Cielos Jemima Cantero Noguera, Alba María Cordone Ramos